C
Celgene (Bristol-Myers Squibb)
Summit, United States
Founded 1986 NYSE: BMY
Nanomedicine Drug Delivery Cancer Nanotherapy Protein Nanoparticles Cell Therapy Nano Nanobiosensors
About
Oncology and immunology therapeutics using nanoparticle formulations
Company Details
- Type
- public
- Employees
- 10000+
- Funding
- BMS Acquired
Key Products
- Abraxane
- Pomalyst
- Cancer Therapies